3DBioFibR, based in Halifax, Nova Scotia, has closed a $3 million equity financing round following a string of recently signed paid partnerships and collaborations across key sectors including tissue engineering, medical devices, defence, cosmetics and apparel with several multinational corporations.

The company’s proprietary dry-spinning platform enables the production of fibres from a wide range of biopolymers with performance metrics that meet or exceed natural tissue strength by up to three times. Compared to conventional techniques like wet spinning and electrospinning, 3DBioFibR’s process also delivers material at over 3,600 times the scale, with vastly improved uniformity and cost-efficiency. These properties position the company’s fibres for use in applications where strength, biocompatibility or scale have previously been limiting factors.

The funding round drew participation from both new and existing investors, including AoA Innovation Fund, Build Ventures, Invest Nova Scotia, and Concrete Ventures and will enable ISO 13485 certification, clean room expansion and manufacturing scale-up to meet soaring demand for next-gen medical and performance biomaterials.

“This investment fuels the next phase of our growth,” said Kevin Sullivan, 3DbioFibR’s CEO. “It enables us to meet growing demand from our commercial partners and to become a qualified supplier for regulated medical and therapeutic applications. ISO 13485 certification is a key step in delivering clinical-grade fibres at the scale and consistency our partners require. We’re excited to expand our impact across industries that urgently need stronger, more sustainable biomaterials.”

“3DBioFibR has accomplished something rare, translating cutting-edge biomaterials science into real commercial traction,” said Patrick Keefe, general partner at Build Ventures. “They’ve partnered with serious players in global industries and built a manufacturing platform that can deliver fibres at a scale and quality the market hasn’t seen before. This team is setting the benchmark in biopolymer fibre manufacturing and we’re proud to support their journey.”

www.3dbiofibr.com